Capital Research Global Investors Hutchmed (China) LTD Transaction History

Capital Research Global Investors

  • $443 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$23.7 - $39.27 $12.8 Million - $21.3 Million
-541,645 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$27.01 - $36.8 $15.9 Million - $21.7 Million
-590,355 Reduced 52.15%
541,645 $15.3 Million
Q4 2019

Feb 18, 2020
BUY
$17.17 - $25.95 $1.15 Million - $1.74 Million
67,000 Added 6.29%
1,132,000 $28.4 Million
Q3 2019

Nov 14, 2019
BUY
$17.84 - $22.69 $19 Million - $24.2 Million
1,065,000 New
1,065,000 $19 Million

Others Institutions Holding HCM

# of Institutions
66
Shares Held
8.25M
Call Options Held
3.8K
Put Options Held
2.4K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email